If you’ve been trading penny stocks for more than one month, you would have to look at the chart of the last month on TNI BioTech Inc. (TNIB) and say OMFG! Although the pink sheet listed, recently massively reverse split, less than $400 in the bank biotech just began trading 3 months ago, TNIB stock price is setting itself up for a nose dive after gaining over 200% this month. If you were a razor-like penny stock trader, this has to be on your short list.
Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
TNIB Stock Chart
Market Cap: 94.32M
Close: 3.96, up 0.93 (30.69%)
Dollar Volume: $426,230
Average Trade Size: 809
Issued and Outstanding: 23,818,058
Float: 1,337,327 (very questionable)
Looking for Hot Penny Stocks?
Click here to Subscribe Today — FREE
TNI Biotech has been running with the bulls since mid-September, but the last week has been an unsustainable run to levels which just simply can not support these gains. Yes, volume has been relatively low so not many shares are being traded. However, basing these gains on their balance sheet and short corporate history seems undeniably ridiculous.
At the end of August, TNI BioTech claimed to acquire the exclusive licensing rights to all of the proprietary technical information, know-how, procedures, IND, protocols, methods, prototypes, designs, data and reports, which are not readily available to others through public means, and which were owned, generated or developed through experiments or testing by Dr. Bernard Bihari. Say that two times out loud within one minute and you win the “It must be true, it was on the internet” trophy of the week.
The deal called for the issuance of 500,000 shares of TNIB stock whereas the Company agreed to maintain the patents and, in cases where additional patents have not been maintained in the last two years, promise to petition the United States Patent and Trademark Office to revive them immediately. “I promise Mom, I’ll clean my room tomorrow.”
Regardless of the details of the acquisition, here is a Company that reported having $369 in cash and no other liquid assets that is gonna go into Nicaragua and Malawi to open and operate clinics for oncology and the treatment of HIV/AIDS and other infectious diseases? C’mon. A pack of cigarettes and $100 will get you any official documentation you could want to claim that anything you are attempting to accomplish is happening — including a new method to curing and treating diseases that the top scientists and facilities int he word have been trying to do for decades now unsuccessfully.
About TNIB Stock
TNI BioTech, Inc. claims to be a biotech company combating fatal diseases through the activation and mobilization of the body’s immune system using our patented immunotherapy with products and technologies designed to harness the power of the immune system to improve the treatment and diagnosis of cancer, infections such as HIV/AIDS and autoimmune diseases.
Bottom Line: TNIB is the best penny stock to short right now. The increase in their PPS in such a short period of time on nothing but MoU and plans is simpy not enough to keep TNIB anywhere over $1. If you are long, perhaps you may want to seek a safety net since there is no way $20,119 in total assets can have a market capitalization of $94.32 million.
Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter
If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks
(We are 100% Anti-Spam and will never rent or sell your information)